HIMS: Showing Signs of Exhaustion: Downside Targets at 42 and 33HIMS: Showing Signs of Exhaustion: Downside Targets at 42 and 33
HIMS appears to be forming a rising wedge pattern, a typically bearish formation that often signals exhaustion of upward momentum.
After several failed attempts to break higher, the price has now started to pull back, suggesting tha
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.60 USD
126.04 M USD
1.48 B USD
204.35 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
ISIN
US4330001060
FIGI
BBG00Q53VYM7
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Related stocks
WHATS NEXT FOR $HIMS?Technical & Fundamental Outlook for NYSE:HIMS : Positioning for a Sustained Bull Run
A comprehensive review of the charts for NYSE:HIMS reveals a compelling narrative of building bullish momentum, suggesting the stock may be on the cusp of its most significant upward move to date. The technical s
$HIMS - Heading to support! The positive reaction in after-hours trading was driven by HIMS's impressive earnings, with revenues nearing the $600 million mark. From a technical analysis perspective, all eyes are now on the 200-day Moving Average. The critical test will be whether the stock can successfully break through and re
HIMS QuantSignals V3 Earnings 2025-11-03HIMS QuantSignals V3 Earnings 2025-11-03
HIMS Earnings Signal | 2025-11-03
• Direction: BUY CALLS | Confidence: 70%
• Entry Plan: Pre Earnings Close | Expiry 2025-11-07
• Strike Focus: $42.00
• Entry Range: $4.80
• Target 1: $9.20
• Stop Loss: $2.30
• Implied Move: $6.65 (14.8%)
• 24h Move: -0.56%
•
$HIMS growth is moderating starting 2025- NYSE:HIMS had explosive growth in 2025 but it will grow only 20% yoy going forward.
- Their eps really sucks and will moderate as well. There is no point in giving a multiple more than 30.
Fair value :
year : 2025 , eps: 0.48 , fair value: 30 x 0.48 =~ $15
year : 2027 , eps: 0.68 , fair value:
HIMS rebounding from 200-day SMA to $60 by end of Nov?HIMS is having a mean reversion back to the 200-day SMA (red line). Last 3 times it touched it, it rebounded at least 30% the month after.
It might take a week or two to form the short term bottom. The blue MACD line seems to be flattening out. Last few times it happens, stock rebounded.
When the
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIMS is 36.98 USD — it has increased by 2.58% in the past 24 hours. Watch Hims & Hers Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Hims & Hers Health, Inc. stocks are traded under the ticker HIMS.
HIMS stock has fallen by −9.23% compared to the previous week, the month change is a −33.13% fall, over the last year Hims & Hers Health, Inc. has showed a 53.57% increase.
We've gathered analysts' opinions on Hims & Hers Health, Inc. future price: according to them, HIMS price has a max estimate of 85.00 USD and a min estimate of 30.00 USD. Watch HIMS chart and read a more detailed Hims & Hers Health, Inc. stock forecast: see what analysts think of Hims & Hers Health, Inc. and suggest that you do with its stocks.
HIMS reached its all-time high on Feb 19, 2025 with the price of 72.98 USD, and its all-time low was 2.72 USD and was reached on May 12, 2022. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 9.04% volatile and has beta coefficient of 2.35. Track Hims & Hers Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hims & Hers Health, Inc. there?
Today Hims & Hers Health, Inc. has the market capitalization of 8.42 B, it has decreased by −6.02% over the last week.
Yes, you can track Hims & Hers Health, Inc. financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. is going to release the next earnings report on Mar 2, 2026. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 0.06 USD per share, whereas the estimation was 0.09 USD resulting in a −36.40% surprise. The estimated earnings for the next quarter are 0.05 USD per share. See more details about Hims & Hers Health, Inc. earnings.
Hims & Hers Health, Inc. revenue for the last quarter amounts to 598.98 M USD, despite the estimated figure of 580.24 M USD. In the next quarter, revenue is expected to reach 619.11 M USD.
HIMS net income for the last quarter is 15.77 M USD, while the quarter before that showed 42.51 M USD of net income which accounts for −62.89% change. Track more Hims & Hers Health, Inc. financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2025, the company has 1.64 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. EBITDA is 174.28 M USD, and current EBITDA margin is 5.76%. See more stats in Hims & Hers Health, Inc. financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hims & Hers Health, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hims & Hers Health, Inc. stock shows the neutral signal. See more of Hims & Hers Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









